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Molecular epidemiology and 
comparative genomics of 
Campylobacter concisus strains 
from saliva, faeces and gut mucosal 
biopsies in inflammatory bowel 
disease
Karina Frahm Kirk  1,2, Guillaume Méric3, Hans Linde Nielsen4, Ben Pascoe  3, Samuel K. 
Sheppard3,5, Ole Thorlacius-Ussing2,6 & Henrik Nielsen  1,2
Campylobacter concisus is an emerging pathogen associated with inflammatory bowel disease (IBD), 
yet little is known about the genetic diversity of C. concisus in relation to host niches and disease. We 
isolated 104 C. concisus isolates from saliva, mucosal biopsies and faecal samples from 41 individuals (26 
IBD, 3 Gastroenteritis (GE), 12 Healthy controls (HC)). Whole genomes were sequenced and the dataset 
pan-genome examined, and genomic information was used for typing using multi-locus-sequence 
typing (MLST). C. concisus isolates clustered into two main groups/genomospecies (GS) with 71 distinct 
sequence types (STs) represented. Sampling site (p < 0.001), rather than disease phenotype (p = 1.00) 
was associated with particular GS. We identified 97 candidate genes associated with increase or 
decrease in prevalence during the anatomical descent from the oral cavity to mucosal biopsies to faeces. 
Genes related to cell wall/membrane biogenesis were more common in oral isolates, whereas genes 
involved in cell transport, metabolism and secretory pathways were more prevalent in enteric isolates. 
Furthermore, there was no correlation between individual genetic diversity and clinical phenotype. This 
study confirms the genetic heterogeneity of C. concisus and provides evidence that genomic variation is 
related to the source of isolation, but not clinical phenotype.
Campylobacter concisus is an emerging pathogen that is a part of the commensal human oral microbiota1. 
Recently, the species has been associated with diseases of the gastrointestinal tract, such as Barrett’s esophagus2, 
prolonged diarrhoea3,4 and inflammatory bowel disease (IBD)5–8. Diversity within C. concisus populations may 
explain differences in pathogenic activity as well as detection of isolates in both patients and healthy control 
individuals9,10. However, the extent of genetic diversity of isolates from different disorders has not been well 
described, and the diversity of multiple isolates from the same individual is unknown.
Various typing methods such as amplified fragment length polymorphisms (AFLP)11,12, 23 S rRNA PCR12,13 
and multi-locus sequence typing MLST14–16 have previously been used for strain typing of C. concisus. MLST is 
widely used as a method for typing that can identify lineages and population structures in a microorganism17, and 
the method has been shown to have a high discriminatory power for Campylobacter jejuni and Campylobacter 
coli18 and for emerging Campylobacter species19. One of the advantages of MLST is that sequence data can be 
easily exchanged between laboratories for use in global epidemiological research.
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In general, these studies have shown a consistent division of C. concisus isolates into two main clusters or 
genomospecies (GS), regardless of typing method. A correlation with clinical presentation has been suggested, 
since isolates from diarrheic individuals were overrepresented in the same GS in previous studies12,13. However, 
this subdivision was not found in subsequent studies from oral isolates15, or diarrheic faecal samples16 where 
pathogenic isolates were equally present in both GS16. Phylogenetic differentiation has also been reported among 
isolates from gastroenteritis and Crohn’s disease, implying genetic differences associated with diseasephenotypes9. 
These studies provide a good basis for considering the molecular epidemiology of C. consisus but further work, 
with large well characterised isolate collections, is necessary to understand how population structure relates to 
clinical significance in these highly diverse, recombining bacteria15. Moreover, most studies have been performed 
with isolates from saliva and faeces, whereas limited information from mucosal biopsy isolates is available. Only 
few studies have used whole genome sequencing to compare C. concisus isolates9,20,21. It has been proposed that 
exotoxin 9, used as a proxy for a group of conserved genes on the UNSWCD plasmid, may be involved in intra-
cellular survival, since this was only detected in the highly invasive strains22. Another gene with a potential role 
in C. concisus pathogenicity is zot, encoding the Zot toxin that targets intercellular tight junctions23–25. Recently, 
Chung et al. analysed the genomes of 27 C. concisus isolates, mostly from the oral cavity20. In that study, novel 
genomic islands containing type IV secretion systems, putative effector proteins and CRISPR-associated proteins 
were identified, with different prevalence between genomospecies.
In this study we investigated oral, gut mucosal and faecal isolates sampled from patients with inflammatory 
bowel disease (IBD), diarrhoae/gastroenteritis (GE), and healthy controls (HC). We used MLST, whole genome 
sequencing, core- and accessory genome characterization to investigate the diversity of a large number of isolates 
from different anatomical sites within individuals, including gut mucosal biopsies from healthy controls.
Results
Population structure and epidemiology. In accordance with previous findings, C. concisus isolates 
clustered into two main groups/genomospecies (GS). When annotated according to disease status, there was 
no difference between GS, as isolates deriving from IBD patients, diarrheic patients and healthy controls were 
present in both clusters (p = 1.00) (Fig. 1A). However, when assessing anatomical site of collection, GS II iso-
lates predominated in gut mucosal samples and GS I in oral samples (p < 0.0001) (Fig. 1B). Faecal isolates were 
equally distributed in both clusters, independent of disease status (p = 1.00). MLST using the combination of loci 
defined by Miller et al.19 revealed a high diversity of C. concisus with 71 ST’s and the following number of alleles: 
aspA:63, atpA:65, glnA:62, gltA:64, glyA:62, ilvD:64 and pgm:63. For comparison, typing by 16 S rRNA, 23 S rRNA 
sequences and MLST using other previously described loci15 was performed. These typing methods showed con-
sistent results with isolates clustering into two groups (data not shown).
Two or more isolates were collected from 27/41 patients (18 IBD, 2 GE, 7 HC). The mean number of isolates 
collected per individual was 3 (1–12). Isolates from 17/27 patients (63%) were genetically different, with isolates 
from seven individuals (4 IBD, 1 GE, 2 HC) being represented in both GS. These findings were independent of 
clinical presentation and sampling site (Supplementary Figure 1).
Pangenome content analysis and identification of genes involved in colonisation. We exam-
ined the prevalence and variation of the 4,798 genes from the pangenome of 113 C. concisus genomes. A total of 
864 core genes were present in all isolates and 1,095 genes were present in >95% isolates (Fig. 2A). The number 
of detected genes per genome differed between the two GS. There was an average of 313 ± 13 more genes per 
genomes in GS II isolates (1,914 ± 7, n = 78) compared to GS I isolates (1602 ± 9, n = 34) (Fig. 2B), which was a 
significant difference (Unpaired two-tailed t test; t = 24.93, df = 110; p < 0.0001). Consequently, the GS-specific 
core genome size was also higher in GS II (1,367 genes, or 71.4% of the GS II average genome size) than in GS 
Figure 1. Genetic relatedness of C. concisus isolates. Each dot represents a single isolate, coloured according to: 
(A) disease phenotype (red = IBD, blue = gastroenteritis (GE), green = healthy controls (HC)) and (B) sample 
collection site (red = gut mucosal biopsies, blue = faeces, green = saliva). Left and right clusters represent 
genomospecies (GS) I and II, respectively. The proportion of isolates from IBD patients and healthy controls in 
the two genomospecies was not statistically different (p = 1.0), whereas isolates from saliva were more frequent 
in GS I compared to gut mucosal biopsy isolates, more frequent in GS II (p < 0.001). Phylogenetic trees were 
created from concatenated sequences of seven housekeeping genes.
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I (975 genes shared by all GS I isolates, or 60.9% of the GS I average genome size), with a slight overrepresenta-
tion of GS II core genes predicted to be involved in amino-acid and carbohydrate metabolism (Supplementary 
Table 1). Also, there were more than twice as many genes absent from all GS I isolates and present in at least one 
GS II isolate than the opposite (1,537 vs. 667 genes, respectively). Overall, this suggests extensive genomic diver-
gence between GS I and GS II lineages in C. concisus that could be related to functional variation.
We identified genes that varied in prevalence in different groups of isolation sites. C. concisus was iso-
lated from 12 distinct body sites. Of these, ten were from biopsies of the gastrointestinal tract (proximal/
distal ileal-anal-pouch, ileum, terminal ileum, cecum, ascending colon, transverse colon, descending colon, sig-
moideum and rectum). In total, our dataset comprised of 14 isolates from saliva, 74 from gastrointestinal biopsies, 
and 25 from faeces (including the nine previously published genomes). We identified 73 genes increasing in prev-
alence from saliva to biopsies to faeces, that had a minimum 30% increase in prevalence between saliva and biop-
sies (Fig. 2C, Supplementary Table 2). Additionally, we identified 24 genes decreasing in prevalence from saliva 
to biopsies to faeces, and that had a minimum 30% decrease in prevalence between saliva and biopsies (Fig. 2D, 
SupplementaryTable 2). Of these 97 genes, 60 had a COG functional assignation, the rest being composed of pre-
dicted hypothetical proteins (Supplementary Table 2). In isolates from gut mucosal biopsies and faeces, there was 
an over-representation of functions involved in amino acid-, carbohydrate- and lipid transport and metabolism 
compared to isolates from the oral cavity. In contrast, oral isolates had more genes involved in cell wall/membrane 
biogenesis and inorganic ion transport, compared to enteric strains (Supplementary Table 2).
Exotoxin 9 and zot. In the 104 isolates from this study, 67 (64%) had either zot or exotoxin 9 DNA, or 
both. Eight isolates had zot only, 50 exotoxin 9 only, and nine had both zot and exotoxin 9. In total, 59 (57%) 
isolates from 26 different patients (IBD n = 15, HC n = 9, GE n = 2), had exotoxin 9 DNA, with the majority 
being gut mucosal isolates (n = 42) (Tables 1 and 2). There was noticeably fewer isolates with exotoxin 9 only 
from IBD patients (37%) compared to HC (70%) and GE patients (71%). Nine isolates were positive for both 
zot and exotoxin 9 DNA, and all these nine isolates were from IBD patients with the majority (n = 6) originating 
from gut mucosal isolates. Isolates positive for zot only, were more prevalent in GS I (6/18) compared to GS II 
(2/39) (p = 0.039), whereas isolates positive for exotoxin 9 only, was higher in GS II (20/39) compared to GS I 
(4/18) (p = 0.004). Isolates with both putative virulence factors were not significantly different between the two 
genomospecies (p = 0.56).
Figure 2. Panel A: Overview of the pangenome and prevalence of detected genes per genome. A total of 864 
core genes were present in all isolates and 1,095 genes were present in > 95% isolates. Panel B: Isolates belonging 
to GS II had a higher number of detected genes per genome compared to isolates from GS I. In average there 
were 313 ± 13 more genes per genomes in GS II isolates (1,914 ± 7, n = 78) compared to GS I isolates (1602 ± 9, 
n = 34) (p < 0.0001). Panel C: Seventy-three genes were found to increase in prevalence from oral isolates to gut 
mucosal isolates and to faecal isolates, with a minimum increase of 30% from saliva to gut mucosal biopsies. 
Panel D: Twenty-four genes decreased in prevalence from saliva to gut mucosal biopsies and to faeces, with a 
minimum 30% decrease from saliva to gut mucosal biopsies.
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The zot gene has previously been described in the reference isolate C. concisus 13826 (ATCC BAA-1457) 
and was also detected in ATCC 33237. These sequences were included in a phylogenetic analysis, which showed 
grouping into two main clusters (Fig. 3). Three isolates were not included in the phylogenetic analysis because 
the genes were located at the end of a contig and were therefore incomplete (AAUH-2010376221 (faecal isolate, 
diarrheic patient, bp = 670), 14HC (mucosal isolate, healthy control, bp = 826), and 11HC (faecal isolate, healthy 
control, bp = 702)). They were, however, included for evaluation of polymorphisms where possible. No patient 
had more than one type of zot, even when detected in samples from different sites. When analyzing nucleotide 
sequence data and amino acid composition, we found that none of our isolates had the zot350–351AC polymorphism 
previously described by Mahendran et al.24. The zotmultiple was detected in three isolates (13826, 44UCsig6 and 
44UCsig-a). We found the zot808T polymorphism only in one mucosal isolate, interestingly from a healthy control 
(14HC). The amino acid substitutions from the polymorphisms sites were equivalent to those previously reported 
by Mahendran et al.24, with a substitution of valine at position 270. We did not find any other nucleotide polymor-
phisms or amino acid substitutions in our data set that correlated to clinical presentation.
Other putative virulence genes. In our isolates, we identified some of the CRISPR-associated genes and 
plasmid integration island genes, previously described by Chung et al.20. Similar to their findings, the preva-
lence of some Cas-proteins were specific to genomospecies, such as Cas1_1, Cas2 and Cas3 which were only 
found in GSII (p < 0.001). In general, CRISPR-associated genes and plasmid integration island genes were gener-
ally more common in isolates from genomospecies II, but there was no difference between clinical presentation 
(Supplementary Table 3).
Discussion
We present analyses of 104 C. concisus isolates from both IBD patients and healthy controls, including samples 
collected from different anatomical sites in the same individual. Previous studies have shown that C. concisus is 
Gene IBD (n = 66) HC (n = 31) GE (n = 7)
zot only 3 (4.5%) 4 (12.9%) 1 (14.3%)
Exotoxin 9 only 26 (39.3%) 19 (61.2%) 5 (71.4%)
zot + exotoxin 9 9 (13.6%) 0 0








zot only 2 (15.3%) 3 (4.2%) 3 (15%)
Exotoxin 9 only 4 (30.7%) 36 (50.4%) 10 (50%)
zot + exotoxin 9 1 (7.1%) 6 (8.4%) 2 (10%)
Table 2. Isolates positive for zot and/or exotoxin 9 in samples according to sample collection site (n = 104).
Figure 3. A phylogenetic tree based on the concatenated sequences of the zot gene, in 14 C. concisus isolates. 
Colours indicate clinical presentation (red = IBD, green = HC), shapes indicate sampling site: (dots = gut 
mucosal biopsies, triangles = saliva samples, diamonds = faecal samples).
www.nature.com/scientificreports/
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genetically heterogeneous, and we now document that this diversity exists throughout the entire gastrointestinal 
tract, regardless of clinical presentation. Reports on the molecular epidemiology of C. concisus have primarily 
included isolates from saliva and faeces with a limited number of isolates from gut mucosa9,15,20. We now expand 
considerably the examination of C. concisus isolates by culture from gut mucosal biopsies from multiple sites of 
the intestine. An important finding is that for several genes the relative frequency increases or decreases in iso-
lates sampled along the gastrointestinal tract. It is possible that as the host niche and microbiome varies, different 
genotypes acquire a competitive advantage and this may be related to the pathogenicity of C. concisus at the gut 
epithelium. It has been suggested that the oral cavity may be the natural reservoir for C. concisus colonisation, and 
genetically different isolates have been isolated from the oral cavity of the same individual1. We found that genetic 
differences exist between isolates sampled at multiple anatomical sites and that there can be different genotypes 
in the same clinical sample. This suggests that multiple different isolates can potentially colonize the gut mucosa.
Some of the isolates collected in this study were sampled at different time points, for one patient four years 
apart. The current understanding of transmission and duration of C. concisus colonisation in humans is very 
limited. While colonisation of the human oral cavity may facilitate human to human transmission, C. concisus 
has also been isolated from domestic pets26, as well as from chicken and beef samples27. Comparing the genetic 
diversity between isolates recovered from different mammalian species has not been performed, but would be 
useful for evaluating transmission sources.
We found, that isolates belonging to GS II generally had larger genomes than isolates from GS I, and that 
gut mucosal and faecal isolates were more predominant in GS II. While we found candidate genes increasing 
and decreasing (respectively) in prevalence from saliva to gut biopsies to faeces, there were few genes that were 
specific to collection site. Previously, particular genes involved in sodium-hydrogen antiporting, sulfite reductase 
and peptidoglycan biosynthesis have been related to the pathogenic activity of C. concisus in IBD9. We found that 
genes involved in transport of nutrients and cell metabolism were more abundant in the enteric isolates, possibly 
indicating, that the intestine is a colonisation site for C. concisus, and relates to the metabolic activity required in 
this niche. Findings of no difference in the existence of C. concisus subtypes between clinical groups support the 
suggestion that C. concisus is not always pathogenic, and that genetic variability reflects the bacterial adaptation to 
different niches of the gastrointestinal tract, rather than disease status of the host. Since the pathogenic activities 
of C. concisus have been elucidated in-vitro studies22,25,28, an explanation could be that C. concisus is a pathobiont, 
which exerts pathogenic activity only when the surrounding environment is suitable, and that this characteristic 
is unrelated to genotype. This is consistent with evidence that there is no correlation between clinical presentation 
and presence of the putative virulence genes zot and exotoxin 9. However, we observed a relatively low prevalence 
of zot in our study (15%) compared to previous findings in which 30% of Australian oral isolates were positive24. 
Since most of the isolates in our study derive from gut mucosal biopsies, this may indicate that certain polymor-
phisms of the zot gene are only present in oral isolates from IBD patients, or that geographical differences exist. 
Isolates that contain both zot and exotoxin 9 DNA have not previously been described in detail. In this study, we 
found nine isolates with both virulence factors, from five different patients that all had IBD. The sample size of our 
present study was not powered to detect a statistically significant difference,but these results could indicate that 
accumulation of several virulence genes may be related to disease phenotype.
We previously found that the prevalence of C. concisus was considerably higher for the UC-IPAA subgroup 
of IBD patients compared to healthy controls8. Patients that have undergone UC-IPAA surgery for UC have the 
most severe form of disease, and we found that the majority of UC-IPAA patients in our study had continued 
clinical and endoscopic signs of inflammation. However, the results of our study do not indicate a correlation 
between genetic diversity of C. concisus and clinical presentation. Therefore, a possible association with disease 
could be related to relative quantities of C. concisus, instead of specific genomospecies. The etiology of IBD is 
multifactorial, but dysbiosis of the intestinal microbiota is believed to be a key initiating factor29. Given the fact 
that in-vitro studies with C. concisus have demonstrated pathogenic capabilities such as induction of apoptosis30, 
as well as epithelial invasion and cytokine production25,31, it seems plausible that pathogenic C. concisus isolates 
could be important in such dysbiotic environments. An interesting approach to understanding the in-vivo actions 
of C. concisus would therefore be to investigate the interactions with other enteric bacteria in health and disease. 
The relationship between C. concisus and the microbiota in five children with CD has been investigated and the 
prevalence of C. concisus was associated with increased levels of Firmicutes reported by abundance levels and 
potential genetic exchange32,33. Studies examining the microbial compositions of the luminal and gut mucosal 
flora in C. concisus positive patients with IBD or diarrhoea, as well as in healthy controls, would be useful for 
understanding the role of this enigmatic organism in intestinal inflammation.
In conclusion, molecular typing of C. concisus isolates from saliva, mucosa and faecal samples of IBD patients 
and healthy controls indicated high genetic diversity among C. concisus isolates regardless of clinical presentation. 
In general, there was a subdivision of isolates into two clusters/genomospecies, related to anatomical sampling 
site. We identified genetic variation associated with the population structure of C. concisus as well as candidate 
genes associated with the colonisation site in humans, notably genes involved in cell transport and metabolism, 
as well as cell wall/membrane biosynthesis. As our data does not support a specific disease related genotype of C. 
concisus, we suggest that the pathogenic potential may be modulated by the specific microbial environment in the 
gut, but further studies are needed to confirm this.
Methods
Isolates and patient characteristics. A total of 104 C. concisus isolates were sequenced and analysed 
in this study, sampled from 41 different adult patients. Two or more isolates were recovered from 27 patients. 
Of all patients, eight had ulcerative colitis (UC), three had Crohn’s disease (CD), 15 had ulcerative colitis with 
previous ileal-pouch-anal-anastomosis surgery (UC-IPAA), three had gastroenteritis (GE) and 12 were healthy 
controls (HC) (Table 3). The mean age was 49 years (range: 20–73). Fifty-four percent of participants were male 
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(22/41). Nine isolates were from UC (1 oral, 7 biopsies, 1 faecal), 16 from CD (2 oral, 13 biopsies, 1 faecal), 41 
from UC-IPAA (5 oral, 27 biopsies, 9 faecal), seven from GE (3 biopsies, 4 faecal) and 31 from HC (5 oral, 21 
biopsies, 5 faecal). A detailed overview of corresponding isolates for all patients is provided in Supplementary 
Table 4. This includes previously sequenced strains8, and two faecal isolates from a study investigating isolates 
from diarrheic patients3. The majority of isolates (n = 102) derive from a previous study aimed at optimizing 
cultivation procedures from mucosal biopsies8. Isolates were randomly chosen across the sampling frame, to cap-
ture as much genetic diversity as possible. Briefly, samples for cultivation were collected from saliva, gut mucosal 
biopsies and faecal samples from each study participant, using the Aalborg two-step incubation procedure and 
cultivation using a filter technique8,34. From agar plates where individual and separable colonies existed, these 
were collected and enumerated accordingly. Isolates were stored at −80 °C until preparation for use in this study 
and the isolates had less than five passages on artificial media. Written informed consent was provided by all 
participants and the studies were approved by the Regional Ethics Committee of Northern Jutland, Denmark 
(N-20013070, N-20110008). All research was conducted in accordance with the Danish Health Act. In addition 
to our isolates, nine publically available genomes from the NCBI database were also included in the comparative 
analysis. These strains were sampled from gut mucosal biopsies of three patients with Crohn’s disease (UNSWCD, 
UNSW2, UNSW3), faecal isolates from patients with gastroenteritis (UNSW1, UNSWCS, ATCC 51562, BAA-
1457 (13826)), one faecal isolate from a healthy person (ATCC 51561) and one oral isolate from a patient with 
periodontitis (ATCC 33237).
DNA extraction and genome sequencing. DNA was extracted using the QIAamp DNA Mini Kit 
(QIAGEN, Crawley, UK), according to manufacturer’s instructions. DNA was quantified using a Nanodrop 
spectrophotometer, as well as the Quant-iT DNA Assay Kit (Life Technologies, Paisley, UK) before sequencing. 
Genome sequencing was performed on an Illumina MiSeq sequencer using the Nextera XT Library Preparation 
Kit with standard protocols. Libraries were sequenced using 2 × 250 bp paired end v3 reagent kit (Illumina), 
following manufacturer’s protocols. Short read paired-end data was assembled using the de novo assembly 
algorithm, SPAdes (version 3.10.035. The average number of contigs was 92 (range: 3–356) for an average total 
assembled sequence size of 1.94 Mbp (range: 1.78–2.22). The average N50 was 97693 (range: 13858–934037) 
and the average GC content was 38.94% (range: 37.26–39.88). An overview of assembly information is provided 
in Supplementary Table 5. Genomes and short data are archived on the NCBI GenBank and SRA depositories, 
associated with BioProject accession # PRJNA395841.
Reference pan-genome construction. A reference pangenome was assembled from a total of 113 C. con-
cisus whole genomes using a previously described method36. Briefly, the 104 genomes from this study and an 
additional 9 C. concisus reference genomes were automatically annotated using the SEED/RAST system37,38 and a 
pangenome reference list of unique genes was assembled using BLAST with the following parameters: a sequence 
was considered to be an allelic variant of an existing gene when local alignment was >70% of sequence identity on 
>10% of the sequence length. Any sequence below these thresholds was considered a novel gene and added to the 
list. The final list of genes was filtered using CD-HIT39 with a sequence identity cut-off of 90% nucleotide identity. 
A total of 4,798 unique genes were discovered and their prevalence was examined in all genomes from this study. 
Functional annotation of the list was made using RPSBLAST 2.2.15 program on the Clusters of Orthologous 
Groups (COG) database (NCBI, 28/03/2017) implemented in the WebMGA server (http://weizhong-lab.ucsd.
edu/metagenomic-analysis/server/cog/). A total of 2,639/4,798 (55%) genes could be assigned to a described 
COG.
Gene-by-gene analyses and genome alignments. Sequence alignments and genome content com-
parison analyses using BLAST were performed gene-by-gene, as implemented in the BIGSdb platform40–42 and 
described in previous Campylobacter studies43–47. Briefly, genes were scanned in genomes using BLAST with the 
following parameters: a gene was considered present in a given genome when its sequence aligned to a genomic 
sequence with >70% sequence identity on >50% of sequence length using BLAST. Genome alignments were 
produced41,42 by concatenating single-gene alignments using MAFFT48.
Typing using MLST and rRNA. Multi locus sequence typing was conducted using the seven loci aspA, 
atpA, glnA, gltA, glyA, ilvD and pgm, described by Miller at al. with sequences obtained from PubMLST (http://
Group N Sex, male (%)
Age, mean 
(range)
Number of isolates Inflammation
Saliva Mucosa Faeces Symptoms (%) Endo-/microscopic (%)
CD 3 2 (33) 39 (24–63) 2 13 1 3(100) 1 (33)
UC 8 3 (37) 52 (33–68) 1 7 1 5 (62) 5 (62)
UC-IPAA 15 9 (60) 41 (21–56) 5 27 9 13 (87) 12 (80)
GE 3 1 (33) 47 (20–65) 0 3 4 3 (100) 0 (0)*
HC 12 7 (58) 60 (45–73) 5 21 5 — —
Total 41 22 (44) 49 (20–73) 13 71 20 24/27 (83) 19/26 (73)
Table 3. Overview of patient characteristics by clinical group (CD: Crohn’s disease, GE: Gastroenteritis, 
HC: Healthy controls, UC: Ulcerative colitis, UC-IPAA: Ulcerative colitis, with previous ileal-pouch-anal-
anastomosis). *Endoscopic/microscopic evaluation not performed for one patient (AAUH-2010376221).
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pubmlst.org)19. The combination of the six loci asd, aspA, atpA, glnA, pgi and tkt previously used by Mahendran 
et al.15 was used for comparison, as well as typing by 16 S rRNA and 23 S rRNA sequences, all obtained from the 
NCBI database (https://www.ncbi.nlm.nih.gov/).
Phylogenetic reconstruction. Phylogenetic trees were inferred using the neighbour-joining algorithm 
from core genome sequence alignments and visualised using MEGA7 software49. Data was analysed using 
Stata 14 (Statacorp LP, Texas, USA). The McNemar chi-squared test was used for comparison of groups, and a 
p-value < 0.05 was considered statistically significant.
Data Availability. Genomes and short data are archived on the NCBI GenBank and SRA depositories, asso-
ciated with 455 BioProject accession # PRJNA395841. Assembled genomes are also shared on figshare under 
DOI: 456 10.6084/m9.figshare.5245219. All MLST sequences are pending submission to the PubMLST 457 data-
base for ST assignment and online accession from NCBI. (http://pubmlst.org/campylobacter/).
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